Cargando…
MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer
MicroRNAs (miRNAs) have recently been recognized as targets for anti-metastatic therapy against cancer malignancy. Development of effective miRNA mediated therapies remains a challenge to both basic research and clinical practice. Here we presented the evidence for a miR-708-5p mediated replacement...
Autores principales: | Wu, Xiaoping, Liu, Tianchi, Fang, Ou, Dong, Wenhua, Zhang, Fengjun, Leach, Lindsey, Hu, Xiaohua, Luo, Zewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823045/ https://www.ncbi.nlm.nih.gov/pubmed/26678031 http://dx.doi.org/10.18632/oncotarget.6594 |
Ejemplares similares
-
The microRNA-708-5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma
por: Feng, Tianyu, et al.
Publicado: (2020) -
MicroRNA-708 emerges as a potential candidate to target undruggable NRAS
por: Pang, Jia Meng, et al.
Publicado: (2023) -
Regulatory roles of microRNA-708 and microRNA-31 in proliferation, apoptosis and invasion of colorectal cancer cells
por: LEI, SAN-LIN, et al.
Publicado: (2014) -
miR-708-5p: a microRNA with emerging roles in cancer
por: Monteleone, Nicholas J., et al.
Publicado: (2017) -
A highly robust and optimized sequence-based approach for genetic polymorphism discovery and genotyping in large plant populations
por: Jiang, Ning, et al.
Publicado: (2016)